Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Canadian Journal of Anesthesia/Journal canadien d'anesthésie
Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 7/2016

01-07-2016 | In reply

In reply: Neuromuscular monitoring should be required when neuromuscular blocking drugs are used: Is it time to change the Canadian guidelines?

Authors: Gregory Dobson, MD, Richard N. Merchant, MD

Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Issue 7/2016

Login to get access

Excerpt

We thank Dr. Hudson for his comments1 in response to publication of the 2016 edition of Guidelines to the Practice of Anesthesia.2 The Canadian Anesthesiologists Society (CAS) standards committee encourages and welcomes feedback related to the Guidelines. …
Literature
1.
Hudson RJ. Neuromuscular monitoring should be required when neuromuscular blocking drugs are used: Is it time to change the Canadian guidelines? Can J Anesth 2016; 63. DOI: 10.​1007/​s12630-016-0639-5.
2.
Merchant R, Chartrand D, Dain S, et al. Guidelines to the practice of anesthesia – revised edition 2016. Can J Anesth 2016; 63: 86-112.CrossRefPubMed
3.
4.
Brull SJ, Murphy GS. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg 2010; 111: 129-40.CrossRefPubMed
5.
Stoelting RK. Residual drug-induced muscle weakness in the postoperative period: a patient safety issue. ASA Newsletter 2015; 79: 2.
Metadata
Title
In reply: Neuromuscular monitoring should be required when neuromuscular blocking drugs are used: Is it time to change the Canadian guidelines?
Authors
Gregory Dobson, MD
Richard N. Merchant, MD
Publication date
01-07-2016
Publisher
Springer US
Published in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Issue 7/2016
Print ISSN: 0832-610X
Electronic ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-016-0640-z

Other articles of this Issue 7/2016

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 7/2016 Go to the issue

Correspondence

The C-MAC® D-BLADE™: use of the guide rail as a guiding channel for a gum elastic bougie

Images in Anesthesia

The “William Tell” sign: difficult airway resulting from cranial transfixion by an arrow

Correspondence

Novel maneuvers to increase the internal jugular vein diameter during ultrasound-guided cannulation

Correspondence

Fellowships and subspecialization in anesthesia: Are they good, bad, or both?

Correspondence

Lack of data on standardized metrics for surgical care in a developing country with middle total expenditure on health

Editorials

Strategies for lung isolation: to block or not to block?